Behshad Sheldon
President Camurus Inc.
Behshad Sheldon (born 1963) was appointed President of Camurus Inc. in 2024 and holds the holds the overall responsibility for leading Camurus’ organization in the US.
She has more than 25 years of experience from leading positions within the international pharmaceutical industry, including as President & CEO of Braeburn Pharmaceuticals up to 2017, and from senior positions within Smithkline Beecham, Bristol-Myers Squibb and Otsuka Pharmaceuticals, where she led successful blockbuster brands such as Glucophage, Plavix, and Abilify. Most recently Behshad was a Managing Director at Biotech Value Advisors where she supported biotech and pharmaceutical companies with pre-launch and commercialization efforts in the US.
Beshad holds a B.Sc. in Neuroscience from University of Rochester.
Other current appointments: Board member of Camurus AB, Chairman of the Board of FORCE (Female Opioid Research and Clinical Experts) in Princeton, New Jersey, Board member of Maxona Pharmaceuticals, Philadelphia, Pennsylvania and of Egetis Therapeutics, Stockholm, Sweden.
Holdings: 1,000 shares